Making Bets on Pharmacies

Brittney Barrett |

The recent earnings for drugstores seem to indicate solid growth compared to the falling numbers in other sectors and the recent movement among top companies from CVS (CVS) to Rite Aid (RAD). For those considering an investment in the sector, there are a number of current news factors that could help some companies achieve above and beyond expectations and others may be dealt a major blow in the next quarter.



Walgreen's (WAG) is currently engaged in a dispute with Express Scripts (ESRX), a pharmacy benefit management company supporting clients  from health maintenance organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, and Government health programs. The absence of ESRX clientele would be a major loss for Walgreen Co. bottom line. The failure for the two companies to reach a resolution that would keep Walgreen stores in the pharmacy-benefit manager's network represents major potential losses for Walgreen’s, at least according to the Credit Suisse analyst Edward Kelly. Kelly downgraded shares of the company from Outperform to Neutral in a note today alongside pessimism surrounding a conclusion to the deal.

In terms, of Express Scripts, the company is confident strong client support will allow them to move forward on the years plans in the absence of a replacement pharmacy without losing too many clients.

What is Walgreen’s loss is a gain for the other top names where Scripts clients will now patronize to have their prescriptions filled. Kelly recommended Rite Aid as a candidate to benefit from the windfall of Walgreen’s exit.

CVS has also shown promise both in terms of its earnings and the potentiality of new clients from Scripts. Net revenues at CVS grew by 12.5 percent to a record $26.7 billion with pharmacy services expanding by 25.8 percent even before the addition of new clients abandoning Walgreen’s.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
AIM.PR.A:CA Aimia Inc. Cumulative Rate Reset Preferred Shares 14.42 -0.12 -0.83 1,200
RAD Rite Aid Corporation 4.00 0.05 1.27 15,561,971 Trade
ESRX Express Scripts Holding Company 61.34 -0.06 -0.10 6,560,967 Trade
CVS CVS Health Corporation 82.44 -0.35 -0.42 6,618,391 Trade

Comments

Emerging Growth

GSV Capital Corp

GSV Capital Corp is an externally managed, non-diversified closed-end management investment company. The Company has elected to be treated as a business development company.

Private Markets

CF0005, LLC dba Mesa-Marshall #1-2

MESA Resources, Inc. ("MESA") is sponsoring the development of the oil & gas well completion project "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development…

Trustify

Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…